Huysse MedConsult SRL

Huysse MedConsult reported total assets of 144,769 € at the end of the 2025 financial year (annual accounts filed with the NBB on 04 Dec 2025).

Company number (CBE) 0778.801.122 · VAT BE0778801122
3370 Boutersem
active in Research and experimental development on biotechnology (NACE 72101)
operating since 17 Dec 2021 (≈ 5 yrs)
Public Public page: latest year only. The score, history and details open with a free account. Create a free account
Idonis solidity score
EDCBA

The score of Huysse MedConsult shows with a free account.

See the score
Profile
SRL since 2021
Components
  • Summary? / 5
    • Balance sheet strength
    • Liquidity
    • Repayment capacity
    • Profitability
    • Trajectory
    • Compliance and register
  • Position in its sectorvs peers
  • Supplier creditat 30 d
  • Borrowing capacityborrowable
  • Valuationcentral

Visible once signed in: create your account, the 14-day Pro trial is free.

Detail

Key figures 2025

Net result66,389 €
Equity51,601 €
Cash123,120 €
EBITDA81,341 €
Total assets144,769 €
The line marks its sector median: 60.4% (425 companies).

Change 2022 → 2025: Equity -32 % Total assets +40 %

Accounts of the company itself (not consolidated).

The full file covers 4 financial years; a free account shows 2. →

Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error

Huysse MedConsult's annual accounts

2025202420232022
Net result66,389 €
Equity51,601 €
Cash123,120 €
EBITDA81,341 €
Total assets144,769 €

Filed annual accounts

  • Year ended 30 Jun 2025filed on 04 Dec 2025
  • Year ended 30 Jun 2024filed on 02 Dec 2024
  • Year ended 30 Jun 2023filed on 27 Nov 2023
  • Year ended 30 Jun 2022filed on 06 Dec 2022

Huysse MedConsult's financial analysis

Management and control of Huysse MedConsult

1 active director(s) in the register.

Huysse MedConsult's shareholders and holdings →

Huysse MedConsult's publications in the Belgian Gazette

Company number, VAT number and registered office

Company number (CBE)
0778.801.122
VAT number
BE0778801122
Peppol
Registered · 0208:0778801122 · as of 10 Nov 2026
Legal form
SRL
Incorporated
17 Dec 2021
Registered office
3370 Boutersem
Latest accounts
2025 · filed on 04 Dec 2025
Activity
Research and experimental development on biotechnology (NACE 72101)

Huysse MedConsult (SRL) has been based in Boutersem since 2021, active in: research and experimental development on biotechnology. For 2025, it reports a net profit of 66,389 € and equity of 51,601 €; its revenue is not published. Its solvency stands at 35.6%, below the median of its sector (60.4%).

Guide: Reading Belgian SME accounts: the five figures that count →

Companies similar to Huysse MedConsult

Companies in the same business, of comparable size and area, outside its group.

Frequently asked questions about Huysse MedConsult

What is the revenue of Huysse MedConsult?

Huysse MedConsult files its accounts in a format where revenue is optional: it is not published for 2025.

What is the VAT number of Huysse MedConsult?

In Belgium, the VAT number is the company number prefixed with BE: BE0778801122 for Huysse MedConsult, if the company is VAT-registered. Its company number (CBE) is 0778.801.122.

Where is the registered office of Huysse MedConsult?

According to the CBE register, the registered office of Huysse MedConsult is in 3370 Boutersem.

What is the equity of Huysse MedConsult?

At the close of the 2025 financial year, the equity of Huysse MedConsult amounts to 51,601 €, a solvency of 35.6% of total assets.

Who manages Huysse MedConsult?

The register lists 1 active mandates at Huysse MedConsult. Names and roles are in the full file, with the deeds published in the Belgian Gazette.

Idonis

The full file of Huysse MedConsult

Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.

Open the full file →
Free account in 30 seconds, by email. No bank card.
Sources : Annual accounts — NBB ↗ Register — CBE ↗ Deeds — Belgian Gazette ↗ · Updated on 16 Aug 2026

No credit card, no commitment.

What each plan unlocks →